Antiemicranici specifici in Europa e nel mondo

Translated title of the contribution: Specific anti-migraine treatments in Europe and in the world

Marta Allena, Salvatore Terrazzino, Ennio Pucci, Cristina Tassorelli

Research output: Contribution to journalArticlepeer-review


This paper deals with symptomatic treatment, which is the first therapeutic approach in patients with migraine. It focuses, in particular, on specific anti-migraine treatments and on the few, but valuable, data on their daily use in different countries, both European and elsewhere in the world. This would seem to be a very important topic, given that the vast majority of migraine patients take symptomatic drugs, prescribed or not prescribed by their doctor, in order to reduce the symptoms of the attack, namely pain but also nausea, photophobia and phonophobia, with the immediate objective of freeing themselves from these (more or less often disabling) symptoms and resuming their activities as quickly as possible.

Translated title of the contributionSpecific anti-migraine treatments in Europe and in the world
Original languageItalian
Pages (from-to)62-67
Number of pages6
JournalConfinia Cephalalgica
Issue number2
Publication statusPublished - Sep 1 2016

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Specific anti-migraine treatments in Europe and in the world'. Together they form a unique fingerprint.

Cite this